Achillion Pharmaceuticals Inc Watch

EX-1

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

12/34/56

EX-1

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

12/34/56

EX-1

from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1

12/34/56

EX-1.1

from 8-K 37 pages Achillion Pharmaceuticals, Inc. Common Stock, $0.001 Par Value Underwriting Agreement

12/34/56

EX-1

from SC 13G 2 pages Joint Filing Statement Statement Pursuant to Rule 13d-1

12/34/56

EX-1

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement

12/34/56

EX-1.1

from 8-K 34 pages Achillion Pharmaceuticals, Inc. (A Delaware Corporation) 12,000,000 Shares of Common Stock Underwriting Agreement

12/34/56

EX-1

from SC 13G 1 page Exhibit 1 Joint Filing Agreement

12/34/56

EX-1.1

from 8-K 30 pages Achillion Pharmaceuticals, Inc. (A Delaware Corporation) 15,000,000 Shares of Common Stock Underwriting Agreement

12/34/56

EX-1.1

from 8-K 30 pages Achillion Pharmaceuticals, Inc. (A Delaware Corporation) 9,600,000 Shares of Common Stock Underwriting Agreement

12/34/56

EX-1

from SC 13D/A 2 pages Agreement

12/34/56

EX-1.1

from 8-K 33 pages Achillion Pharmaceuticals, Inc. 10,275,000 Shares of Common Stock Underwriting Agreement January 22, 2010

12/34/56

EX-1.1

from S-1/A 28 pages Shares Achillion Pharmaceuticals, Inc. Common Stock Underwriting Agreement

12/34/56

EX-1.1

from S-1/A 28 pages Shares Achillion Pharmaceuticals, Inc. Common Stock Underwriting Agreement

12/34/56